Lancet Commission predicts sharp increase in global prostate cancer cases

FHS
April 5, 2024
3:09 am

Cases of prostate cancer are projected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, with low- and middle-income countries (LMICs) predicted to see the highest increases in cases, according to The Lancet Commission on prostate cancer which will be launched by a presentation at the European Association of Urology Congress.

Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure

AMSTERDAM — Semaglutide 2.4 mg (Wegovy) led to clinically meaningful reductions in symptoms and weight among patients with obesity and heart failure with preserved ejection

August 26, 2023

Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc

How does a startup compete with the likes of Eli Lilly and Novo Nordisk in the rapidly evolving field of weight loss drugs? And how

April 18, 2024

Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.